We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+16.44%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$18.2B
AUM Growth
+$1.49B
Cap. Flow
-$841M
Cap. Flow %
-4.62%
Top 10 Hldgs %
18.93%
Holding
2,614
New
37
Increased
460
Reduced
567
Closed
1,419

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$87.4M
2
LRCX icon
Lam Research
LRCX
+$69.8M
3
V icon
Visa
V
+$62.2M
4
FISV
Fiserv Inc
FISV
+$55.7M
5
XLNX
Xilinx Inc
XLNX
+$41.2M

Sector Composition

Rank Sector Weight
1 Technology 23.75%
2 Healthcare 13.19%
3 Financials 11.7%
4 Consumer Discretionary 8.69%
5 Industrials 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POR icon
276
Portland General Electric
POR
$5.82B
$14.1M 0.08%
330,083
-26,638
-7% -$1.09M
UCB
277
United Community Banks
UCB
$4.26B
$13.7M 0.08%
482,313
-38,123
-7% -$900K
AMN icon
278
AMN Healthcare
AMN
$1.35B
$13.7M 0.08%
200,154
-12,342
-6% -$805K
RS icon
279
Reliance Steel & Aluminium
RS
$20.6B
$13.5M 0.07%
113,061
-46,134
-29% -$5.33M
ZTS icon
280
Zoetis
ZTS
$32.7B
$13.5M 0.07%
81,512
+2,403
+3% +$391K
CAH icon
281
Cardinal Health
CAH
$53.7B
$13.4M 0.07%
249,823
-77,303
-24% -$4.01M
PEG icon
282
Public Service Enterprise Group
PEG
$38.7B
$13.3M 0.07%
228,830
-9,305
-4% -$542K
FOE
283
DELISTED
Ferro Corporation
FOE
$13.3M 0.07%
907,683
-72,417
-7% -$1M
RP
284
DELISTED
RealPage, Inc.
RP
$13.2M 0.07%
151,570
-5,723
-4% -$375K
DGX icon
285
Quest Diagnostics
DGX
$26B
$13.2M 0.07%
110,813
+2,462
+2% +$300K
HPP
286
Hudson Pacific Properties
HPP
$758M
$13.2M 0.07%
78,249
-2,344
-3% -$387K
PM icon
287
Philip Morris
PM
$309B
$13.1M 0.07%
158,510
-3,221
-2% -$251K
KSS icon
288
Kohl's
KSS
$2.16B
$13M 0.07%
319,931
+317,855
+15,311% +$9.25M
ELME
289
Elme Communities
ELME
$145M
$13M 0.07%
599,887
-63,229
-10% -$1.35M
IJH icon
290
iShares Core S&P Mid-Cap ETF
IJH
$121B
$13M 0.07%
282,230
+2,480
+0.9% +$104K
SO icon
291
Southern Company
SO
$108B
$12.9M 0.07%
209,916
-13,444
-6% -$808K
TRV icon
292
Travelers Companies
TRV
$81.1B
$12.6M 0.07%
89,916
+309
+0.3% +$39.7K
PSX icon
293
Phillips 66
PSX
$82.9B
$12.6M 0.07%
180,155
+61,204
+51% +$3.59M
SLGN icon
294
Silgan Holdings
SLGN
$4.51B
$12.5M 0.07%
338,363
-55,985
-14% -$2.02M
ADSK icon
295
Autodesk
ADSK
$51.8B
$12.5M 0.07%
40,842
+2,068
+5% +$545K
NUVA
296
DELISTED
NuVasive, Inc.
NUVA
$12.5M 0.07%
221,182
-17,698
-7% -$870K
SUPN icon
297
Supernus Pharmaceuticals
SUPN
$2.7B
$12.4M 0.07%
491,734
-38,726
-7% -$834K
EPD icon
298
Enterprise Products Partners
EPD
$83.7B
$12.3M 0.07%
630,271
+12,625
+2% +$235K
NVO
299
Novo Nordisk
NVO
$228B
$12.3M 0.07%
351,218
+4,208
+1% +$145K
NFLX icon
300
Netflix
NFLX
$307B
$12.2M 0.07%
225,740
-2,220
-1% -$113K

Similar funds

Glenmede Trust's Q4 2020 Portfolio in Review

As of Q4 2020, Glenmede Trust held 2,614 positions worth $18.2B, up 9% from $16.7B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Glenmede Trust withdrew a net $841M in Q4 2020, closing 1,419 positions and reducing 567 holdings. Its most notable exit was H&R Block, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Glenmede Trust opened a new position in CryoPort worth $974K.

  • Glenmede Trust's largest Q4 2020 buy was CryoPort: 22,210 shares worth $974K.
  • Glenmede Trust added most to iShares Core S&P Small-Cap ETF in Q4 2020, an estimated $38.7M increase.
  • Glenmede Trust's biggest Q4 2020 reduction was Progressive, cutting an estimated $87.4M.
  • Glenmede Trust fully exited H&R Block in Q4 2020, selling an estimated $18.3M.
  • Glenmede Trust's ten largest holdings make up 19% of its $18.2B portfolio in Q4 2020.
  • Glenmede Trust opened 37 new positions and closed 1,419 in Q4 2020.
  • Glenmede Trust's portfolio value rose 9% quarter-over-quarter to $18.2B.

Based on Glenmede Trust's 13F filing for Q4 2020, filed 16 Feb 2021.